Therapy Areas: Autoimmune
16 November 2018 - - US-based clinical stage biopharmaceutical company Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) has received interim topline results from the first two cohorts of its Phase 2a...
15 November 2018 - Saniona AB (STO:SANION) reported on Wednesday net profit of SEK15.3m, or diluted EPS of SEK0.68, for the third quarter of 2018, from July 2018 to September 2018.This was an improvem...
14 November 2018 - - The US Food and Drug Administration has approved Keytruda, US-based pharmaceutical company Merck's (NYSE: MRK) anti-PD-1 therapy, for the treatment of patients with hepatocel...
13 November 2018 - - US-based immunotherapy company Alpine Immune Sciences, Inc. (NASDAQ: ALPN) has advanced its oncology programme, the company said.

Following promising preclinical data...
9 November 2018 - - US-based clinical-stage company Vedanta Biosciences has released preclinical data for VE800, the company's orally-administered, live biotherapeutic product candidate in immuno...
9 November 2018 - Saniona AB (STO:SANION), a biotechnology company within ion-channel research, announced on Thursday the entering into a one -year option agreement with biotechnology company Initiato...
Related Headlines